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Previews(Rasmussen et al., 2015) recently shown
to be essential for transmission by fleas
(Sun et al., 2014), indicating that the
Bronze Age Y. pestis strains were not
flea transmitted.
How pathogenic were these ancient
Y. pestis strains? The most ancient ones
lack the isoleucine to threonine mutation
at position 259 in the Pla protein, a muta-
tion that has been shown to be essential
for developing bubonic, but not pneu-
monic, plague (Zimbler et al., 2015). The
new genomes—if we can call Bronze
Age genomes ‘‘new’’—report important
insights into virtually all of the genes
currently known to be involved in
Y. pestis pathogenicity (Rasmussen
et al., 2015). This provides a uniquely
documented historical record of events
in Yersinia genome evolution, allowing us
to date the appearance of functionally
relevant mutations. The well-dated nature
of the remains that harbor these Yersinia
strains furthermore puts very robust
constraints on the timeline of Yersinia
evolution, which has been an issue of
considerable interest lately (Wagner
et al., 2014).
There is a rich history of recurrent pla-
que epidemics during recorded human
history going back to Roman times (Dran-
court and Raoult 2002). The new findings514 Cell Host & Microbe 18, November 11, 20indicate that humans have been exposed
to Y. pestis for much longer than any pre-
vious historical record suggested. Indeed,
prior work had not provided direct molec-
ular evidence for Y. pestis biology from
material older than 1,500 years (Bos
et al., 2011; Wagner et al., 2014). The
new findings are thus an important mile-
stone that pushes the record of plague
evolution back by thousands of years,
filling in gaps in our understanding of
what happened during one of human-
kind’s most traumatic encounters with
microbial growth.
It wasn’t long ago that movies brought
the horrific image of genetically resur-
rected, meat-eating dinosaurs into our
lives. With these new 5,000-year-old
bacterial genome sequences, and the ca-
pabilities imparted by modern genome
synthesis, we are closer than ever before
to being able to bring the genomes of the
dead back to life. Our past is catching up
with us quickly, so we had better beware,
for the most important take-home lesson
fromall humanencounterswith thepowers
of nature is simple—nature always wins.ACKNOWLEDGMENTS
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HIV commonly escapes host antiviral immunity by downregulating cell-surface immunoreceptors. In a recent
issue of Cell Host & Microbe, Matheson et al. (2015) systematically examined how HIV-1 infection remodels
the T cell surface and identified serine carriers SERINC3/5 and alanine transporter SNAT1 as targets of HIV-1
Nef and Vpu, respectively.One of the hallmarks of HIV-1 infection is
its ability to quietly spread throughout
the host, often for extended periods oftime, without raising major alarms within
the immune system or causing overt
signs of disease. The virus accomplishesthis amazing feat in part by modifying the
expression of numerous host proteins,
particularly at the membrane of infected
Figure 1. HIV-1 Vpu Decreases Cellular Uptake of Alanine to Prevent CD4+ T Cell
Mitogenesis via SNAT1 Downregulation
(Left side) In the absence of Vpu, stimulation of CD4+ T cells with mitogenic stimuli results in increased
surface expression of the alanine transporter SNAT1, leading to a larger intracellular alanine pool and
increased mitogenesis. (Right side) HIV-1 Vpu downregulates SNAT1 from the cell surface by binding to
SNAT1 to induce its ubiquitination and degradation via recruitment of the SCFbTrCP E3 ubiquitin ligase
complex. SNAT1 downregulation results in decreased alanine uptake and reduced intracellular free
alanine pools, dramatically reducing the mitogenic capacity of CD4+ T cells. Given that mitogenesis is a
prerequisite for T cell activation, this mechanism may represent a novel mode of immune evasion, as well
as a new paradigm for viral disruption of immunometabolism.
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Previewscells. Two HIV-1 proteins, Nef and Vpu,
function primarily to alter the protein
composition at the cell surface to pro-
mote virus replication and spread, while
at the same time preventing detection
of infected cells by the immune system.
Targets of HIV-1 Nef and Vpu have clas-
sically been found using non-systematic
candidate approaches and include the
HIV-1 receptor CD4, the restriction fac-
tor Tetherin, and the MHC-I molecules
HLA-A/B (Tokarev and Guatelli, 2011),
as well as several other receptors impor-
tant for adaptive and innate immunity,
including the NK cell-activating mole-
cules NTB-A and PVR, the NKT cell-acti-
vating CD1d, and the leukocyte homing
molecules CCR7 and CD62L. In a recent
issue of Cell Host & Microbe, Matheson
et al. (2015) combine plasma membrane
enrichment methods with a series of
cutting edge, quantitative mass-spec-
trometry-based techniques to investi-
gate the effects of HIV-1 infection on
the global protein composition of the
T cell membrane in an attempt todiscover new targets of Nef and Vpu.
This unbiased and comprehensive anal-
ysis revealed the downregulation of
more than 100 HIV-1 targets. Although
the majority of downregulated surface
proteins appear to be involved in cell
adhesion, and to a lower extent leuko-
cyte activation, a surprising number
of membrane-spanning small molecule
transporter proteins were also identified,
including members of the solute carrier
(SLC) and serine incorporator (SERINC)
families of proteins.
Interestingly, of the membrane trans-
porter proteins identified in this study,
most are poorly characterized, and the
transport function of many of these can-
didates has not been validated. For
example, SNAT1 is a membrane protein
that has been shown to transport a range
of amino acids across the cell membrane
using in vitro overexpression systems,
yet was traditionally thought of as a gluta-
mine transporter in the brain (Varoqui
et al., 2000). Matheson et al. (2015)
show that SNAT1 is poorly expressed inCell Host & Microbe 18, Nhuman resting CD4+ T cells but is
dramatically induced following mitogenic
T cell stimulation. Furthermore, they
reveal that SNAT1 is downregulated
from the surface of primary CD4+ T cells
and is degraded by Vpu through a pro-
cess that relies on recruitment of the
SCFb-TrCP E3 ubiquitin ligase complex
and SNAT1 ubiquitination. Importantly,
using Consumption and Release metabo-
lomics, they elegantly show that CD4+
T cells greatly increase their alanine up-
take in response to mitogenic stimulation
in a SNAT1-dependent manner and that
this uptake promotes cell activation.
Extracellularly acquired alanine therefore
appears to contribute directly to the cell’s
free alanine pool, and Vpu-mediated
SNAT1 downregulation denies T cells
the alanine required to undergo mitogen-
esis (Figure 1). Unlike CD4 downregula-
tion, SNAT1 downregulation activity ap-
pears pervasive among Vpu variants
from pandemic group M HIV-1 and is
found to varying degrees in the related
HIV-1 group N and the SIVcpz Ptt lineage
(an SIV strain infecting central Pan troglo-
dytes troglodytes chimpanzees) that gave
rise to the pandemic M group. In
contrast, this activity is completely ab-
sent from more distantly related HIV-1
groups (O and P) and other SIV lineages
such as SIVcpz pts (SIV infecting eastern
P.t. schweinfruthii chimpanzees) and
SIVguenon (SIV infecting guenon mon-
keys). This phylogeny suggests that
Vpu-mediated SNAT1 downregulation
was acquired recently and may make an
important contribution to the enhanced
pathogenicity of the HIV-1 group M
viruses.
Vpu-mediated SNAT1 downregulation
may contribute to HIV-1 pathogenesis in
other ways. Another hallmark of HIV-1
infection is the rapid establishment of viral
reservoirs: populations of infected cells
that are protected from the host immune
system either by virtue of their physiolog-
ical state or their anatomical location
within the body. In fact, these reservoirs
represent the principal source of viral
persistence during antiretroviral therapies
and are a major obstacle toward an HIV
cure. One type of viral reservoir consists
of long-lived resting memory CD4+
T cells found throughout the body (Chun
et al., 2015). This cell population is char-
acterized by an overall reduced metabolic
rate and the absence of HIV-activatingovember 11, 2015 ª2015 Elsevier Inc. 515
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Previewstranscription factors. This cellular environ-
ment is conducive to the establishment of
latent infection with little to no viral gene
expression, leaving these cells invisible
to the immune system. Whether
decreasing the alanine pool within in-
fected T cells through Vpu-mediated
SNAT1 downregulation contributes to
reservoir-promoting T cell quiescence
by inhibiting mitogenesis remains an
important question for the future.
Although this notion requires testing,
there is good precedence for its validity,
as it has previously been shown that
T cell activation requires a dramatic in-
crease in amino acid metabolism (Wang
et al., 2011).
Matheson et al. also identified the
putative serine carriers SERINC3 and
SERINC5 as targets of HIV-1 Nef. These
proteins contain ten to eleven putative
transmembrane domains, suggesting a
possible transporter function. To date
however, SERINC proteins have only
been described functionally as ‘‘incorpo-
rator’’ proteins responsible for transport-
ing serine into membranes, where it
can subsequently be incorporated into
phosphatidylserine and sphingolipids (In-
uzuka et al., 2005). Expression of Nef in
primary CD4+ T cells was found sufficient
to downregulate SERINC3/5 from the cell
surface.
For over 20 years, a scientific enigma
has surrounded the HIV-1 Nef accessory
protein. Namely, Nef expressed in virus-
producing cells is well known to increase
virion infectivity, yet how Nef achieves
this has remained elusive. Excitingly,
two research groups have recently iden-
tified SERINC3/5 as the long sought after
host factors modulated by Nef that
restrict HIV-1 infectivity. Both Rosa
et al. (2015) and Usami et al. (2015)
have convincingly demonstrated that
these proteins are packaged into prog-
eny HIV-1 virions in the absence of Nef,
resulting in a block of infection in target
cells prior to reverse transcription.
Expression of Nef in virus-producing
cells results in exclusion of SERINC3/5
from virions, rescuing virion infectivity.
Although SERINC3/5 act synergistically,
SERINC5 appears to provide greater
restriction.
Very little is known about SERINC
expression profiles and anti-HIV activity.
Rosa et al. (2015) show that SERINC5
expression varies widely between dif-516 Cell Host & Microbe 18, November 11, 20ferent cell lines but is generally ex-
pressed at higher levels on lymphocytic
cells, while Usami et al. (2015) demon-
strate that SERINC3/5 mRNAs are
expressed at the highest levels in pe-
ripheral blood mononuclear cells. Math-
eson et al. (2015) futher show that
SERINC3/5 are expressed in isolated
CD4+ T cells. Although the mechanism
underlying the SERINC3/5-mediated
block remains to be elucidated, this dis-
covery has already opened exciting new
avenues of investigation. For example,
given the previously established role of
SERINC proteins in phospholipid pro-
duction, it is possible that SERINC3/5
reduce infectivity by altering the lipid
composition of virion particles. Indeed,
the lipid composition of the HIV-1 enve-
lope has been associated with the de-
gree of virion infectivity (Waheed and
Freed, 2010). In addition, both Rosa
and Usami note that virion entry does
not appear to be inhibited prior to mem-
brane fusion but rather seems to be
blocked at the stage of fusion pore
expansion, the most energy costly step
in viral entry (Cohen and Melikyan,
2004). As membrane lipid composition
has already been implicated in the pore
expansion process (Ciechonska and
Duncan, 2014), it is tempting to specu-
late that altering the phospholipid envi-
ronment in the vicinity of virion-to-cell
fusion allows SERINC3/5 to interfere
with the delivery of the HIV-1 core into
new host cells. However, the direct
requirement of SERINC3/5 serine in-
corporator function in restriction of
viral infectivity remains to be demon-
strated. Moreover, one could wonder if
SERINC3/5 downregulation on virus-
producing cells alters the cell membrane
lipid composition and whether these
changes affect cell-to-cell interactions,
including virological and immunological
synapse formation.
Although their primary amino acid se-
quences suggest possible transporter
function, the ability of SERINC proteins
to transport serine across the plasma
membrane has so far been poorly stud-
ied. For example, SERINC1 has been
shown to have no effect on the cellular
flux of serine, but SERINC1 localizes to
the ER and therefore would not be ex-
pected to be exposed to extracellular
serine pools (Inuzuka et al., 2005).
Meanwhile the works of Matheson,15 ª2015 Elsevier Inc.Rosa, and Usami taken together clearly
demonstrate that SERINC3/5 localize to
the cell surface. However, the serine
transport capability of these proteins
has yet to be investigated. Therefore,
SERINC3/5 downregulation from the
cell membrane may serve two distinct
functions in infected cells: both in-
creasing virus particle infectivity and
perhaps inhibiting T cell activation by
preventing amino acid transport (similar
to SNAT1).
Alanine and serine are non-essential
amino acids, capable of being synthe-
sized within the cell. How the uptake of
exogenous non-essential amino acids
could be important for cellular meta-
bolism remains unclear. Matheson et al.
(2015) demonstrate convincingly that
although SNAT1’s alanine uptake func-
tion promotes primary CD4+ T cell
activation in response to mitogenic
stimuli, there is still a net release of
alanine from the cell, suggesting that
T cells may treat amino acids differently
when they are acquired exogenously
compared to those endogenously pro-
duced. Indeed, this seems to be the
case for alanine as demonstrated by
metabolic experiments using radiola-
belled extracellular alanine or glucose
(the precursor to intracellular alanine
synthesis). This study, therefore, not
only reveals interesting new information
about HIV-1 pathogenesis but also pro-
vides key insight into the normal
workings of amino acid metabolism
and its regulatory implications for T cell
mitogenesis.
The work by Matheson et al. (2015) is
seminal both in terms of methodology
and discovery. By using a plethora of cut-
ting edge techniques, this group has not
only identified new cell-surface targets
of HIV-1 Nef and Vpu but has also defined
a unique paradigm of HIV interference
with immunometabolism. Clearly, this
study marks only the beginning of a fasci-
nating story that will shed new light on
an important but still poorly understood
aspect of the interactions between HIV-1
and its host.
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Many intracellular pathogens, including Salmonella typhimurium, trigger autophagy in host cells, which is
widely thought to restrict intracellular growth and survival. In this issue of Cell Host & Microbe, Kreibich
et al. (2015) demonstrate a role for the autophagic machinery in the repair of damaged Salmonella-containing
vacuoles (SCVs).Macroautophagy (herein referred to as
autophagy) is a highly conserved intracel-
lular process that delivers unwanted or
damaged cytoplasmic components to
lysosomes for degradation. This process
involves the complex interplay of more
than 36 autophagy-related (ATG) proteins
that work in a coordinated manner to
enclose cytoplasmic material in a
double-membrane-bound vacuole (the
autophagosome), which then fuses with
lysosomes to form degradative autolyso-
somes. In this manner, autophagy func-
tions as a quality control mechanism,
eliminating protein aggregates and
damaged organelles to maintain cellular
homeostasis (Mostowy, 2013). However,
many studies over the last 10 years indi-
cate that cells can also utilize autophagy
for the elimination of invading pathogens
(Cemma and Brumell, 2012).
Indeed, elegant studies of Listeria,
Shigella, Mycobacteria, and Salmonella
pathogenesis underscore the important
role played by antibacterial autophagy(xenophagy) in the restriction of bacterial
replication (reviewed in Cemma and Bru-
mell, 2012). Of these, Salmonella enterica
serovar Typhimurium (S. typhimurium) is
perhaps the best understood. Salmonella
express two Type Three secretion sys-
tems (T3SSs) encoded by Salmonella
pathogenicity islands (SPI)-1 and -2.
These needle-like complexes penetrate
host membranes and are used to deliver
distinct arrays of bacterial effectors into
host cells. While the SPI-1 T3SS is
required for active invasion, expression
of the SPI-2 T3SS promotes intracellular
survival within a modified phagosomal
compartment called the Salmonella-con-
taining vacuole (SCV). After the early
stages of infection, the SPI-1 system is
generally downregulated, and the phago-
somal environment (low pH, lowMg2+ and
Fe3+ content, low nutrient availability) trig-
gers expression of the SPI-2 TTSS (for re-
view, see Figueira and Holden, 2012).
Despite their differential regulation,
expression of SPI-1 and SPI-2 T3SSeffector proteins can overlap, and coop-
erate in forming the SCV (Agbor and
McCormick, 2011).
As a mechanism of antibacterial de-
fense, autophagy appears to target Sal-
monella in two ways. While most bacteria
are contained within SCVs, a small pro-
portion of Salmonella escapes the vacu-
ole and can hyperreplicate in the cytosol.
These cytosolic Salmonella do not go
unnoticed, and are tagged by ubiquitin
soon after their release from the SCV
(Figure 1, pathway #1). Ubiquitylation
leads to the recruitment of a variety of
autophagy adapters including SQSTM1/
p62, NDP52 (nuclear dot protein
52 kDa), and optineurin (OPTN) (Mostowy,
2013), which bind to ubiquitylated bacte-
ria via an ubiquitin (Ub)-binding domain
and link them to nascent autophago-
somes through their interaction with an
autophagosomal membrane-anchored
member of the ATG8 family (LC3). Once
sequestered within a completed autopha-
gosome, bacteria are killed within theovember 11, 2015 ª2015 Elsevier Inc. 517
